Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

AMRXAMRX
Showing 8 of 30 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in AMNEAL PHARMACEUTICALS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 2.2M shares of AMRX (AMNEAL PHARMACEUTICALS INC), worth $27.1M as of 2026-Q1. The position was increased (+1.9% shares). AMRX represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$27.1M

Current Shares

2.2M

Total Value Change

+$19.5M

Total Shares Change

+982,141

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.2M
+1.9%
$27.1M0.0%$13.31
29
2025-Q4
Increased
2.1M
+3.0%
$27M0.0%$12.88
30
2025-Q3
Increased
2.1M
+14.3%
$20.8M0.0%$9.87
32
2025-Q2
Increased
1.8M
+3.1%
$14.7M0.0%$8.13
29
2025-Q1
Increased
1.8M
+14.8%
$14.8M0.0%$8.28
32
2024-Q4
Increased
1.5M
+9.6%
$12.2M0.0%$7.83
31
2024-Q3
Increased
1.4M
+16.9%
$11.7M0.0%$8.19
32
2024-Q2
Decreased
1.2M
-2.3%
$7.6M0.0%$6.35
0

Other major holders of AMRX: BlackRock, Inc., VANGUARD GROUP INC, UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used